Q1 2026 Earnings Call February 25, 2026 5:00 PM ESTCompany ParticipantsTushar Jain - Head of Investor RelationsSassine Ghazi - ...
Mutuum Finance (MUTM) has officially confirmed a major step in its roadmap with the activation of its V1 protocol on the ...
DUBAI, United Arab Emirates, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The decentralized finance industry is currently witnessing a steady shift from conceptual designs to functional technical implementations ...
Researchers in the U.S. have developed a set of guidelines and protocols to assess the performance of three-terminal (3-T) and four-terminal (4-T) tandem solar cells, including those with subcells ...
Highlights: First participant enrolled and dosed with NUZ-001 in Regimen I of the HEALEY ALS Platform Trial evaluating ...
The real competitive advantage in stablecoins, the moat that holds competitors at bay, now lies in the distribution held by ...
It’s a matchup that could’ve happened at the N.J. Catholic School Duals, but the regular-season best was saved for last on Thursday in Jersey City. NJ.com No. 3-ranked Christian Brothers visited No. 2 ...
SAN DIEGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics ...
Founded by Dr. Dorra Frikha, a PhD-trained scientist in bone mechanics, DKGlow is a biotech-driven skincare brand rooted in mitochondrial research.
Dosing has begun in a new regimen of the HEALEY ALS platform trial, its ninth, which is testing the oral therapy NUZ-001 for ...
World Liberty Financial proposes 6-month WLFI token lock-up for governance participation, featuring Node tiers and 2% staking rewards tied to voting activity.
The first participant has been dosed in Regimen I of the HEALEY ALS Platform Trial evaluating Neurizon Therapeutics’ lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results